Indefinite Delivery Contract 36C25723D0039

Award Date 4/28/23
Last Date to Order 4/19/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded an indefinite delivery contract to Biofire Diagnostics, LLC to provide Biofire Film Array reagents. Biofire Diagnostics, LLC was awarded three firm fixed price delivery orders totaling $1,243,817.20 to supply these reagents from October 2021 through September 2026 in Emigration Canyon, Utah. The reagents are used with Biofire's Film Array system, which can rapidly detect respiratory,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single award, firm fixed price Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $755,525.82 to provide BioFire consumables. The contract has a period of performance from September 15, 2023 through September 14, 2024 and will be performed in Amarillo, Texas. BioFire consumables are reagents and supplies used with Biomerieux's BioFire FilmArray system. The...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded an indefinite delivery contract vehicle to Biofire Diagnostics, LLC for the provision of Biofire reagents and associated products. Under the terms of the award vehicle, three firm fixed price delivery orders were issued for reagents OY, OY1, and an unspecified reagent. The delivery orders have potential values of $550,736.25, $550,736.25, and $549,856.05 respectively, and run from...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded Biomerieux Inc. multiple blanket purchase agreements and call contracts from April 2023 through September 2024 totalling approximately $215,000. Biomerieux Inc. will provide VIDAS diagnostic testing platforms, reagents, and related services as the prime contractor. Performance will occur at Biomerieux's facility in Emigration Canyon, Utah to support infectious disease testing for...
The Department of Veterans Affairs Veterans Health Administration awarded Biofire Diagnostics, LLC an indefinite delivery contract with a potential value of $904,153.25 to provide gastrointestinal and respiratory reagents for the Biofire DX Film Array system. The contract is a single award with no set-aside and orders may be placed through March 1, 2026. Three firm fixed price delivery orders have been issued against the contract to date for reagents to support the Biofire Film Array system used...
The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics. The single-award BPA, valued at up to $2,971,499.40, is for the supply of Biomerieux's proprietary reagents, diagnostic equipment, and associated maintenance services to the VA's VISN 17 network. The contract is established under the Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, enabling the VA to...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price delivery order to BioMérieux Inc., through its BioMérieux, Inc. division, for the provision of the BioFire TORCH system and associated reagents. The $3,090,938.56 contract is for the supply of this proprietary automated diagnostic platform used for rapid pathogen identification. This delivery order is likely issued under one of BioMérieux's established federal Indefinite Delivery Vehicles (IDVs), such as its $194 million...
The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide reagents and E-test strips. The contract has a ceiling value of $200,000 and a period of performance through September 30, 2025. This is a single-award BPA issued under the VA's Veterans Integrated Service Network 1 (VISN 1) to support the agency's clinical diagnostics and infectious disease testing requirements across its healthcare...
  • 36C25723D0039
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded an indefinite delivery contract to Biomerieux Inc. to supply BIOFIRE REAGENTS in support of VA medical and laboratory programs. The contract carries a potential value of $360,000 and permits orders to be placed through April 2028.

A firm fixed price delivery order valued at $64,460.79 was also awarded under this contract. The delivery order requires Biomerieux Inc. to provide BIOFIRE REAGENTS for use at facilities located in Emigration Canyon, Utah. Performance is required through April 2024. No set-aside provisions were applied to this award or delivery order. As the prime contractor, Biomerieux Inc. will utilize this contracting vehicle to regularly supply reagents and testing products to various VA medical centers and laboratories nationwide over the next five years, helping the VA conduct efficient diagnostic screening and treatment monitoring for the veterans it serves.

Generated 1/5/24, 8:22 PM